Cornerstone Investment Partners’s Protagonist Therapeutics PTGX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$275K	Buy	4,980 +3	+0.1%	+$166	0.01%	117
2025 Q1	$241K	Sell	4,977 -439	-8%	-$21.2K	0.01%	111
2024 Q4	$209K	Sell	5,416 -5	-0.1%	-$193	0.01%	189
2024 Q3	$244K	Buy	+5,421	New	+$244K	0.01%	146